Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
- 1 January 2001
- journal article
- review article
- Published by Elsevier BV in Chest
- Vol. 119 (1), 321S-336S
- https://doi.org/10.1378/chest.119.1_suppl.321s
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patientsAmerican Heart Journal, 1996
- Subcutaneous heparin in postangioplasty management: Comparative trial with intravenous heparinAmerican Heart Journal, 1993
- Preprocedural anticoagulation does not reduce angioplasty heparin requirementsAmerican Heart Journal, 1993
- Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplastyAmerican Heart Journal, 1991
- The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984